Solbec have been given a great opportunity to repeat the performance of this drug while it was in Phase 1 trial. The phase 1 patient was in end stage renal cell cancer and that patient is still in REMISSION today. Great news for the patient and hopefully for this next patient. Goods news all round. Go SBP and Coramisine
- Forums
- ASX - By Stock
- SBP
- chance to crack into market
SBP
solbec pharmaceuticals limited
chance to crack into market
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.